Cancer micrometastases (Q34978121)

5 August 2017

1 reference

title

Cancer micrometastases (English)

1 reference

Catherine Alix-Panabières

5 August 2017

3

Sabine Riethdorf

0 references

series ordinal

2

object named as

Catherine Alix-Panabières

0 references

Klaus Pantel

series ordinal

1

object named as

Klaus Pantel

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

Nature Reviews Clinical Oncology

5 August 2017

published in

1 reference

5 August 2017

volume

6

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

339-351

1 reference

Circulating breast cancer cells are frequently apoptotic

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Tumor cell detection in peripheral blood and bone marrow

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

The impact of nodal isolated tumor cells on survival of breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Prognostic Value of Immunohistochemically Identifiable Tumor Cells in Lymph Nodes of Patients with Completely Resected Esophageal Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of occult sentinel lymph node micrometastases by immunohistochemistry in breast cancer. An NSABP protocol B-32 quality assurance study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection and characterization of putative metastatic precursor cells in cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Isolation of rare circulating tumour cells in cancer patients by microchip technology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

A rare-cell detector for cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

High speed detection of circulating tumor cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

The epithelial-mesenchymal transition generates cells with properties of stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Models, mechanisms and clinical evidence for cancer dormancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

A pooled analysis of bone marrow micrometastasis in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumor cells in patients with breast cancer dormancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Cancer micrometastasis and tumour dormancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

HER-2/neu expression in primary and metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

HER2 gene status in primary breast cancers and matched distant metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

HER-2 gene amplification can be acquired as breast cancer progresses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Adaptive immunity maintains occult cancer in an equilibrium state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Tumor metastasis: mechanistic insights and clinical challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

31 March 2020

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Stem Cells and Cancer: Two Faces of Eve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Mechanisms of Disease: cancer stem cells--targeting the evil twin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Dissecting the metastatic cascade

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Bone-marrow haematopoietic-stem-cell niches

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Comparative evaluation of urokinase‐type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Epithelial-mesenchymal transitions: twist in development and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Random mutations, selected mutations: A PIN opens the door to new genetic landscapes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of mutations in EGFR in circulating lung-cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: A preliminary report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of carcinoembryonic antigen messenger RNA-expressing cells in portal and peripheral blood during surgery does not influence relapse in colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase-polymerase chain reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Surfactant protein gene expressions for detection of lung carcinoma cells in peripheral blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of circulating cancer cells in lung cancer patients with a panel of marker genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Circulating tumor cells predict survival in patients with metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.44

ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients

31 March 2020

1 reference

12 December 2020

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

1 reference

12 December 2020

Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.

1 reference

12 December 2020

Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.

1 reference

12 December 2020

Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage

1 reference

12 December 2020

Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.

1 reference

12 December 2020

International Union Against Cancer. Classification of isolated tumor cells and micrometastasis

1 reference

12 December 2020

Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells

1 reference

12 December 2020

Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer

1 reference

12 December 2020

10.1038/NRCLINONC.2009.44

Identifiers

DOI

1 reference

release_i55q2wnzwvcmpkufo4kvvwzyf4

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i55q2wnzwvcmpkufo4kvvwzyf4

24 November 2022

mapped directly with Wikidata item

1 reference